Results 201 to 210 of about 160,800 (350)

Eyes Offshore: Reporting the Eye Health Needs of Refugees and Asylum Seekers in Australia's Offshore Detention Centres

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background In the last two decades, over 250 000 refugees and asylum seekers have arrived in Australia, many of whom experience significant health problems. Information about their eye health is scarce, particularly for those detained offshore. This is the first study to explore the eye health and services available to this population, helping
Marcel M. Nejatian, Rosie Dawkins, Ebrar Al‐Yasery, Hessom Razavi   +3 more
wiley   +1 more source

Ocular perfusion and age‐related macular degeneration [PDF]

, 2001
Thomas A. Ciulla, Alon Harris, Bruce Martin   +2 more
openalex   +1 more source

Video-evoked neuromarkers of visual function in age-related macular degeneration. [PDF]

Front Hum Neurosci
Renton AI, Klein DJ, Livezey JA, Nemrodov D, Wolfer S, Hanina A, Van De Ville D.   +6 more
europepmc   +1 more source

Cataract Surgery in the Small Adult Eye: A Review

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Modern cataract surgery continues to advance, yet intraocular lens (IOL) based surgery in the small adult eye remains challenging. Thorough preoperative assessment and surgical preparation optimise postoperative outcomes in these cases. Advances in IOL power calculation, including artificial intelligence‐driven formulas, improve accuracy ...
Jonathan E. Moore, Richard N. McNeely, Salissou Moutari   +2 more
wiley   +1 more source

Clinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear [PDF]

, 2001
B. A. Lafaut
openalex   +1 more source

Harnessing nanofibers for targeted delivery of phytoconstituents in age-related macular degeneration. [PDF]

Drug Deliv
Andrades U, Gaikar S, Nathani K, Sawarkar S, Omri A.   +4 more
europepmc   +1 more source

FAMILIAL MACULAR DEGENERATION [PDF]

British Journal of Ophthalmology, 1935
openaire   +3 more sources

Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Intravitreal bevacizumab has been used off‐label to treat multiple ocular conditions for almost two decades. Reference bevacizumab, Avastin, was discontinued in Australia in 2021. A bevacizumab biosimilar, MVASI, was approved by the Therapeutic Goods Administration for the treatment of metastatic cancer in 2020.
Hanru Wang, Bobak Bahrami, Sonia Huang, Marzieh Tahmasebi Sarvestani, Sudha Cugati, Stewart Lake, Weng Onn Chan, Devaraj Supramaniam, Matthew Little   +8 more
wiley   +1 more source

Prospective Study of Alcohol Consumption and the Risk of Age-Related Macular Degeneration

, 2000
Eunyoung Cho
openalex   +1 more source

Risk of macular degeneration with statin use should be interpreted with caution [PDF]

, 2001
R. van Leeuwen, Johannes R. Vingerling, Paulus T.V.M. de Jong   +2 more
openalex   +1 more source